Skip to main content
Erschienen in: Clinical Rheumatology 11/2019

20.07.2019 | Original Article

Does symptomatic knee osteoarthritis increase the risk of all-cause mortality? Data from four international population-based longitudinal surveys of aging

verfasst von: Zidan Yang, Guanghua Lei, Xiaoxiao Li, Yilun Wang, Zikun Xie, Xiurui Zhang, Yuchen He, Yilin Xiong, Tubao Yang

Erschienen in: Clinical Rheumatology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aimed at examining the association between symptomatic knee osteoarthritis and all-cause mortality based on four population-based longitudinal surveys.

Method

Data were retrieved from the English Longitudinal Study of Aging (ELSA), the Survey of Health, Aging and Retirement in Europe (SHARE), the Korean Longitudinal Study of Aging (KLoSA), and the Indonesian Family Life Survey (IFLS). The association between symptomatic knee osteoarthritis and all-cause mortality over the 8- to 12-year follow-up period was assessed using Cox-proportional hazard models.

Results

In the entire sample of 59,522 participants (4823 with symptomatic knee osteoarthritis; 54,699 without symptomatic knee osteoarthritis [control group]; mean age: 61.8 years; female percentage: 55.3%), 8375 died (937 in the symptomatic knee osteoarthritis group, 7438 in the control group) during the follow-up period. Patients with symptomatic knee osteoarthritis had a higher risk of all-cause mortality than control group without adjusting for potential confounders in each survey, and the unadjusted hazard ratios (HRs) of all-cause mortality were 1.32 (95% confidence interval [CI] 1.18 to 1.47) in ELSA, 1.40 (95%CI 1.24 to 1.56) in SHARE, 1.25 (95%CI 1.06 to 1.47) in KLoSA, and 1.65 (95%CI 1.31 to 2.07) in IFLS. However, with adjustment of potential confounders, the corresponding HRs dropped to 1.07 (95%CI 0.94 to 1.20) in ELSA, 1.08 (95%CI 0.97 to 1.22) in SHARE, 0.91 (95%CI 0.77 to 1.08) in KLoSA, and 0.89 (95%CI 0.66 to 1.21) in IFLS, respectively.

Conclusions

In these four population-based longitudinal studies, no association between symptomatic knee osteoarthritis and increased risk of all-cause mortality was observed after adjusting for potential confounders.
Key Points
• This study evaluated the association between symptomatic knee OA and the risk of all-cause mortality among the participants retrieved from four large population-based longitudinal studies across the world.
• No association between symptomatic knee osteoarthritis and increased risk of all-cause mortality was observed after considering potential confounders, and our findings were consistent with the results derived from four independent longitudinal studies.
• The present study included four international population-based longitudinal studies, comprising both developed and developing areas, which allowed the findings to be interpreted under larger circumstance.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat GBD 2015 DALYs and HALE Collaborators (2016) Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1603–1658. https://doi.org/10.1016/S0140-6736(16)31460-X CrossRef GBD 2015 DALYs and HALE Collaborators (2016) Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1603–1658. https://​doi.​org/​10.​1016/​S0140-6736(16)31460-X CrossRef
2.
Zurück zum Zitat GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1260–1344. https://doi.org/10.1016/S0140-6736(17)32130-X CrossRef GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1260–1344. https://​doi.​org/​10.​1016/​S0140-6736(17)32130-X CrossRef
4.
Zurück zum Zitat Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1323–1330. https://doi.org/10.1136/annrheumdis-2013-204763 CrossRefPubMed Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1323–1330. https://​doi.​org/​10.​1136/​annrheumdis-2013-204763 CrossRefPubMed
5.
Zurück zum Zitat Kadam UT, Jordan K, Croft PR (2004) Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis 63(4):408–414CrossRef Kadam UT, Jordan K, Croft PR (2004) Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis 63(4):408–414CrossRef
6.
Zurück zum Zitat van Dijk GM, Veenhof C, Schellevis F, Hulsmans H, Bakker JP, Arwert H, Dekker JH, Lankhorst GJ, Dekker J (2008) Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet Disord 9:95. https://doi.org/10.1186/1471-2474-9-95 van Dijk GM, Veenhof C, Schellevis F, Hulsmans H, Bakker JP, Arwert H, Dekker JH, Lankhorst GJ, Dekker J (2008) Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet Disord 9:95. https://​doi.​org/​10.​1186/​1471-2474-9-95
7.
Zurück zum Zitat Nielen MM, van Sijl AM, Peters MJ, Verheij RA, Schellevis FG, Nurmohamed MT (2012) Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. BMC Musculoskelet Disord 13:150. https://doi.org/10.1186/1471-2474-13-150 Nielen MM, van Sijl AM, Peters MJ, Verheij RA, Schellevis FG, Nurmohamed MT (2012) Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. BMC Musculoskelet Disord 13:150. https://​doi.​org/​10.​1186/​1471-2474-13-150
8.
Zurück zum Zitat Nitter A, Forseth K (2013) Mortality rate and causes of death in women with self-reported musculoskeletal pain: results from a 17-year follow-up study. Scand J Pain 4(2):86–92CrossRef Nitter A, Forseth K (2013) Mortality rate and causes of death in women with self-reported musculoskeletal pain: results from a 17-year follow-up study. Scand J Pain 4(2):86–92CrossRef
9.
Zurück zum Zitat Macfarlane GJ, McBeth J, Silman AJ (2001) Widespread body pain and mortality: prospective population based study. BMJ 323(7314):662–665CrossRef Macfarlane GJ, McBeth J, Silman AJ (2001) Widespread body pain and mortality: prospective population based study. BMJ 323(7314):662–665CrossRef
20.
Zurück zum Zitat Alcser KH, Benson G, Börsch-Supan A, Brugiavini A, Christelis D, Croda E, Das M, de Luca G, Harkness J, Hesselius P, Jappelli T, Jürges H, Kalwij A, Kemperman ML, Klevmarken A, Lipps O, Paccagnella O, Padula M, Perrachi F, Rainato R, van Soest A, Swensson B, Vis C, Weber G, Weerman B (2005) The Survey of Health, Aging, and Retirement in Europe – Methodology. http://www.share-project.org/data-documentation/methodology-volumes.html. Accessed 26 Nov 2018 Alcser KH, Benson G, Börsch-Supan A, Brugiavini A, Christelis D, Croda E, Das M, de Luca G, Harkness J, Hesselius P, Jappelli T, Jürges H, Kalwij A, Kemperman ML, Klevmarken A, Lipps O, Paccagnella O, Padula M, Perrachi F, Rainato R, van Soest A, Swensson B, Vis C, Weber G, Weerman B (2005) The Survey of Health, Aging, and Retirement in Europe – Methodology. http://​www.​share-project.​org/​data-documentation/​methodology-volumes.​html. Accessed 26 Nov 2018
30.
Zurück zum Zitat Hochberg MC (2008) Mortality in osteoarthritis. Clin Exp Rheumatol 26(5 Suppl 51):S120–S124PubMed Hochberg MC (2008) Mortality in osteoarthritis. Clin Exp Rheumatol 26(5 Suppl 51):S120–S124PubMed
33.
Zurück zum Zitat GBD (2016) Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1211–1259. https://doi.org/10.1016/S0140-6736(17)32154-2 CrossRef GBD (2016) Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1211–1259. https://​doi.​org/​10.​1016/​S0140-6736(17)32154-2 CrossRef
Metadaten
Titel
Does symptomatic knee osteoarthritis increase the risk of all-cause mortality? Data from four international population-based longitudinal surveys of aging
verfasst von
Zidan Yang
Guanghua Lei
Xiaoxiao Li
Yilun Wang
Zikun Xie
Xiurui Zhang
Yuchen He
Yilin Xiong
Tubao Yang
Publikationsdatum
20.07.2019
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 11/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04672-5

Weitere Artikel der Ausgabe 11/2019

Clinical Rheumatology 11/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.